AKEBIA THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.34 USD | +0.75% |
|
-1.47% | +8.06% |
| 04-23 | Averoa Seeks EU Approval for Chronic Kidney Disease Drug | MT |
| 04-16 | Akebia Therapeutics, Inc. and STA Pharmaceutical Hong Kong Limited Enters into Second Amendment to the Supply Agreement | CI |
Quotes 5-day view
Delayed Quote Nasdaq| 2024-04-23 | 2024-04-24 | 2024-04-25 | 2024-04-26 | |
|---|---|---|---|---|
| Last | 1.37 $ | 1.37 $ | 1.33 $ | 1.34 $ |
| Volume | 2 108 817 | 1 535 781 | 2 561 124 | 2 475 964 |
| Change | +0.74% | 0.00% | -2.92% | +0.75% |
| Opening | 1.38 | 1.37 | 1.35 | 1.32 |
| High | 1.41 | 1.40 | 1.35 | 1.35 |
| Low | 1.35 | 1.35 | 1.31 | 1.29 |
Performance
| 1 day | +0.75% | ||
| 1 week | -1.47% | ||
| Current month | -26.78% | ||
| 1 month | -40.18% | ||
| 3 months | -17.28% | ||
| 6 months | +59.50% | ||
| Current year | +8.06% | ||
| 1 year | +46.87% | ||
| 3 years | -57.73% | ||
| 5 years | -78.96% | ||
| 10 years | -94.17% |
Volumes
marketsDaily volume
2 475 964
Estimated daily volume
2 475 964
Avg. Volume 20 sessions
3 227 437
Daily volume ratio
0.77
Avg. Volume 20 sessions USD
4 324 765.58
Record volume 1
84 387 410
Record volume 2
81 420 240
Record volume 3
81 393 290
Capital turnover ratio
0.02
Float rotation
0.02
Basic data
Capitalization (USD)
280 558 848
Net sales (USD)
194 623 000
Number of employees
167
Sales / Employee (USD)
1 165 407
Free-Float
89.8 %
Free-Float capitalization (USD)
252 216 150
Average Daily Capital Traded
1.54%
Highs and lows
1 week
1.29
1.41
1 month
1.291.93
Current year
1.212.48
1 year
0.782.48
3 years
0.244.33
5 years
0.2413.71
10 years
0.2431.00
Indicators
Moving average 5 days
1.35
Moving average 20 days
1.48
Moving average 50 days
1.58
Moving average 100 days
1.49
Price spread / (MMA5)
+0.90%
Price spread / (MMA20)
+10.07%
Price spread / (MMA50)
+17.64%
Price spread / (MMA100)
+10.94%
STIM
RSI 9 days
29.76
RSI 14 days
36.92
Sector Comparison - Bio Therapeutic Drugs
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| +0.75% | -1.47% | +8.06% | +46.87% | 281M | ||
| -0.06% | +0.81% | -2.31% | +17.12% | 103B | ||
| -0.84% | -1.52% | +0.56% | +11.47% | 95.28B | ||
| +0.90% | +3.56% | +1.69% | +1.90% | 22.15B | ||
| +0.58% | +0.46% | -17.37% | -21.94% | 21.02B | ||
| +2.04% | -2.57% | -9.30% | -29.08% | 18.15B | ||
| +3.17% | +1.71% | -41.01% | -36.05% | 16.73B | ||
| +3.38% | +18.58% | -14.85% | -39.89% | 16.05B | ||
| -1.28% | +3.02% | +3.21% | +33.45% | 13.68B | ||
| +1.08% | +11.37% | +33.54% | +5.44% | 12.17B | ||
| +1.98% | -1.93% | -24.71% | -34.18% | 8.24B | ||
| +7.91% | +17.17% | +299.30% | +278.94% | 8.19B | ||
| -0.75% | -3.05% | +7.90% | +76.54% | 7.76B | ||
| +0.95% | +0.62% | +0.17% | +49.70% | 7.71B | ||
| +5.81% | +6.81% | -54.46% | -71.56% | 7.17B | ||
| +0.72% | +5.24% | -1.21% | +30.43% | 6.99B | ||
| Average | +1.65% | +3.69% | +11.83% | +19.95% | ||
| Weighted average by Cap. | +0.59% | +1.87% | +2.09% | +10.65% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Last transactions
4051912101c69f2560660095c9c.-iG2oarsb1_kzjhxj3RLMVabCru5N49Ia4C0BJdaCOw.s1DR0-uqHQXcmlE55wcMYTvra_jQb_kgAPneUcQZap29GNLnyZYEL662aQ
| Date | Price | Volume | Daily volume |
|---|---|---|---|
| 16:00:00 | 1.34 | 18,699 | 2,340,393 |
| 15:59:59 | 1.33 | 100 | 2,321,694 |
| 15:59:56 | 1.33 | 100 | 2,321,594 |
| 15:59:55 | 1.34 | 200 | 2,321,494 |
| 15:59:55 | 1.333 | 200 | 2,321,294 |
| 15:59:55 | 1.33 | 100 | 2,321,094 |
| 15:59:55 | 1.34 | 600 | 2,320,994 |
| 15:59:54 | 1.33 | 200 | 2,320,394 |
| 15:59:54 | 1.33 | 395 | 2,320,194 |
| 15:59:54 | 1.33 | 200 | 2,319,799 |
Monthly variations
Annual change
| 2024 | +8.06% | ||
| 2023 | +114.90% | ||
| 2022 | -74.47% | ||
| 2021 | -19.29% | ||
| 2020 | -55.70% | ||
| 2019 | +14.29% | ||
| 2018 | -62.81% | ||
| 2017 | +42.84% | ||
| 2016 | -19.43% | ||
| 2015 | +11.00% | ||
| 2014 | -56.40% |
- Stock Market
- Equities
- AKBA Stock
- Quotes Akebia Therapeutics, Inc.
